Survival by Time-to-Administration of Amiodarone, Lidocaine, or Placebo in Shock-Refractory Out-of-Hospital Cardiac Arrest.
Joshua R LuptonMatthew R NethRitu SahniJonathan JuiLynn WittwerCraig D NewgardMohamud R DayaPublished in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2023)
The early administration of amiodarone, particularly within 8 minutes, is associated with greater survival to admission, survival to discharge, and functional survival compared to placebo in patients with an initial shockable rhythm.